Lexicon Pharmaceuticals Ownership 2024 | Who Owns Lexicon Pharmaceuticals Now?
Institutional Ownership
69.35%
Insider Ownership
1.15%
Retail Ownership
29.51%
Institutional Holders
65.00
Lexicon Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | 53.16% | 7.19% | 117,553,284 | - | - | 282,127,882 | Mar 31, 2024 |
| FMR LLC | 6.28% | 0.00% | 13,894,062 | 11,617,594 | 510.33% | 33,345,749 | Mar 31, 2024 |
| BLACKROCK INC. | 3.48% | 0.00% | 7,693,277 | 688,124 | 9.82% | 18,463,864 | Mar 31, 2024 |
| VANGUARD GROUP INC | 2.89% | 0.00% | 6,401,225 | 420,854 | 7.04% | 15,362,940 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.60% | 0.16% | 3,542,000 | 3,542,000 | 100.00% | 8,500,800 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | 0.00% | 2,389,137 | 40,221 | 1.71% | 5,734,687 | Mar 31, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 1.08% | 0.35% | 2,382,286 | - | - | 5,717,486 | Mar 31, 2024 |
| STATE STREET CORP | 0.90% | 0.00% | 1,987,510 | 95,191 | 5.03% | 4,770,024 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.89% | 0.00% | 1,972,200 | 1,972,200 | 100.00% | 4,733,280 | Mar 31, 2024 |
| PINNACLE ASSOCIATES LTD | 0.79% | 0.07% | 1,747,830 | 17,009 | 0.98% | 4,194,792 | Mar 31, 2024 |
| BVF INC/IL | 0.76% | 0.11% | 1,686,924 | -22,748,708 | -93.10% | 4,048,618 | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | 0.64% | 0.00% | 1,417,950 | -472,250 | -24.98% | 3,403,080 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.64% | 0.02% | 1,404,928 | 1,404,928 | 100.00% | 3,371,827 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.43% | 0.04% | 960,150 | 960,150 | 100.00% | 5,348,625 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.40% | 0.00% | 881,123 | 16,948 | 1.96% | 2,114,695 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.39% | 0.00% | 866,556 | 6,968 | 0.81% | 2,079,735 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.31% | 0.00% | 686,418 | 686,418 | 100.00% | 1,647,403 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.26% | 0.00% | 584,386 | 584,386 | 100.00% | 1,402,526 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.24% | 0.00% | 534,184 | -1,098,992 | -67.29% | 1,282,042 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.24% | 0.00% | 524,177 | 113,131 | 27.52% | 1,258,025 | Mar 31, 2024 |
Lexicon Pharmaceuticals's largest institutional shareholder is ARTAL GROUP S.A., holding 53.16% of the company's total share outstanding, currently valued at $282.13M. The top 10 institutional shareholders own together 72.16% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | 53.16% | 7.19% | 117,553,284 | - | - | 282,127,882 | Mar 31, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.13% | 0.37% | 293,092 | 42,169 | 16.81% | 703,421 | Mar 31, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 1.08% | 0.35% | 2,382,286 | - | - | 5,717,486 | Mar 31, 2024 |
| BOULDER HILL CAPITAL MANAGEMENT LP | 0.12% | 0.25% | 256,400 | 256,400 | 100.00% | 615,360 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.60% | 0.16% | 3,542,000 | 3,542,000 | 100.00% | 8,500,800 | Mar 31, 2024 |
| BVF INC/IL | 0.76% | 0.11% | 1,686,924 | -22,748,708 | -93.10% | 4,048,618 | Mar 31, 2024 |
| PINNACLE ASSOCIATES LTD | 0.79% | 0.07% | 1,747,830 | 17,009 | 0.98% | 4,194,792 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.13% | 0.06% | 293,333 | -486,744 | -62.40% | 704,000 | Mar 31, 2024 |
| PROSPERITY FINANCIAL GROUP, INC. | 0.01% | 0.05% | 31,500 | - | - | 75,600 | Mar 31, 2024 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 0.02% | 0.04% | 35,714 | - | - | 86,000 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.43% | 0.04% | 960,150 | 960,150 | 100.00% | 5,348,625 | Mar 31, 2024 |
| VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.02% | 12,415 | 12,415 | 100.00% | 29,796 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.64% | 0.02% | 1,404,928 | 1,404,928 | 100.00% | 3,371,827 | Mar 31, 2024 |
| LIFESTEPS FINANCIAL, INC. | 0.00% | 0.02% | 10,000 | - | - | 24,000 | Mar 31, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 0.02% | 0.01% | 46,930 | 18,601 | 65.66% | 113,000 | Mar 31, 2024 |
| KWB WEALTH | 0.02% | 0.01% | 40,640 | - | - | 97,536 | Mar 31, 2024 |
| COYLE FINANCIAL COUNSEL LLC | 0.01% | 0.01% | 12,500 | 12,500 | 100.00% | 30,000 | Mar 31, 2024 |
| CHEMISTRY WEALTH MANAGEMENT LLC | 0.01% | 0.01% | 12,000 | - | - | 28,800 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.14% | 0.01% | 319,058 | 319,058 | 100.00% | 766,000 | Mar 31, 2024 |
| BBR PARTNERS, LLC | 0.01% | 0.01% | 30,000 | 30,000 | 100.00% | 72,000 | Mar 31, 2024 |
The largest Lexicon Pharmaceuticals shareholder by % of total assets is ARTAL GROUP S.A.. The company owns 117.55M shares of Lexicon Pharmaceuticals (LXRX), representing 7.19% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 6.28% | 0.00% | 13,894,062 | 11,617,594 | 510.33% | 33,345,749 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.60% | 0.16% | 3,542,000 | 3,542,000 | 100.00% | 8,500,800 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.89% | 0.00% | 1,972,200 | 1,972,200 | 100.00% | 4,733,280 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.64% | 0.02% | 1,404,928 | 1,404,928 | 100.00% | 3,371,827 | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.43% | 0.04% | 960,150 | 960,150 | 100.00% | 5,348,625 | Mar 31, 2024 |
| BLACKROCK INC. | 3.48% | 0.00% | 7,693,277 | 688,124 | 9.82% | 18,463,864 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.31% | 0.00% | 686,418 | 686,418 | 100.00% | 1,647,403 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.26% | 0.00% | 584,386 | 584,386 | 100.00% | 1,402,526 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.23% | 0.00% | 499,172 | 499,172 | 100.00% | 1,198,014 | Mar 31, 2024 |
| VANGUARD GROUP INC | 2.89% | 0.00% | 6,401,225 | 420,854 | 7.04% | 15,362,940 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.14% | 0.01% | 319,058 | 319,058 | 100.00% | 766,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 0.00% | 290,900 | 290,900 | 100.00% | 698,160 | Mar 31, 2024 |
| BOULDER HILL CAPITAL MANAGEMENT LP | 0.12% | 0.25% | 256,400 | 256,400 | 100.00% | 615,360 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.24% | 0.00% | 524,177 | 113,131 | 27.52% | 1,258,025 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.06% | 0.00% | 136,200 | 97,800 | 254.69% | 326,880 | Mar 31, 2024 |
| STATE STREET CORP | 0.90% | 0.00% | 1,987,510 | 95,191 | 5.03% | 4,770,024 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 95,184 | 95,184 | 100.00% | 228,000 | Mar 31, 2024 |
| NATIXIS ADVISORS, L.P. | 0.04% | 0.00% | 86,094 | 86,094 | 100.00% | 207,000 | Mar 31, 2024 |
| LAZARD FRERES GESTION S.A.S. | 0.02% | 0.00% | 50,000 | 50,000 | 100.00% | 119,000 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.02% | - | 49,943 | 49,943 | 100.00% | 119,863 | Mar 31, 2024 |
As of Mar 31 2024, Lexicon Pharmaceuticals's largest institutional buyer is FMR LLC. The company purchased 11.62M stocks of LXRX, valued at $33.35M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 0.76% | 0.11% | 1,686,924 | -22,748,708 | -93.10% | 4,048,618 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.04% | - | 90,136 | -2,953,155 | -97.04% | 216,326 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.24% | 0.00% | 534,184 | -1,098,992 | -67.29% | 1,282,042 | Mar 31, 2024 |
| MORGAN STANLEY | 0.11% | - | 244,209 | -673,479 | -73.39% | 586,101 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.06% | 0.00% | 134,477 | -651,683 | -82.89% | 322,745 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.13% | 0.06% | 293,333 | -486,744 | -62.40% | 704,000 | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | 0.64% | 0.00% | 1,417,950 | -472,250 | -24.98% | 3,403,080 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -412,175 | -100.00% | - | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -359,210 | -100.00% | - | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -323,968 | -100.00% | - | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -282,467 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | 0.01% | - | 17,548 | -207,450 | -92.20% | 42,115 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | - | - | 10 | -150,090 | -99.99% | 23,000 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.04% | - | 85,872 | -124,853 | -59.25% | 206,092,000 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -103,144 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.07% | 0.00% | 156,214 | -79,125 | -33.62% | 374,914 | Mar 31, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 64,619 | -62,397 | -49.13% | 155,000 | Mar 31, 2024 |
| AMUNDI | - | - | - | -54,532 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -54,248 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.13% | 0.00% | 292,006 | -49,071 | -14.39% | 700,815 | Mar 31, 2024 |
As of Mar 31 2024, Lexicon Pharmaceuticals's biggest institutional seller is BVF INC/IL. The company sold -22.75M shares of LXRX, valued at $4.05M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1.60% | 0.16% | 3,542,000 | 3,542,000 | 100.00% | 8,500,800 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.89% | 0.00% | 1,972,200 | 1,972,200 | 100.00% | 4,733,280 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.64% | 0.02% | 1,404,928 | 1,404,928 | 100.00% | 3,371,827 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.26% | 0.00% | 584,386 | 584,386 | 100.00% | 1,402,526 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.23% | 0.00% | 499,172 | 499,172 | 100.00% | 1,198,014 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.14% | 0.01% | 319,058 | 319,058 | 100.00% | 766,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 0.00% | 290,900 | 290,900 | 100.00% | 698,160 | Mar 31, 2024 |
| BOULDER HILL CAPITAL MANAGEMENT LP | 0.12% | 0.25% | 256,400 | 256,400 | 100.00% | 615,360 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.04% | 0.00% | 95,184 | 95,184 | 100.00% | 228,000 | Mar 31, 2024 |
| NATIXIS ADVISORS, L.P. | 0.04% | 0.00% | 86,094 | 86,094 | 100.00% | 207,000 | Mar 31, 2024 |
| LAZARD FRERES GESTION S.A.S. | 0.02% | 0.00% | 50,000 | 50,000 | 100.00% | 119,000 | Mar 31, 2024 |
| WEDBUSH SECURITIES INC | 0.02% | 0.00% | 41,650 | 41,650 | 100.00% | 100,000 | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | 0.02% | - | 40,001 | 40,001 | 100.00% | 87,602 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | 0.00% | 34,433 | 34,433 | 100.00% | 82,639 | Mar 31, 2024 |
| BBR PARTNERS, LLC | 0.01% | 0.01% | 30,000 | 30,000 | 100.00% | 72,000 | Mar 31, 2024 |
| CERITY PARTNERS LLC | 0.01% | 0.00% | 22,512 | 22,512 | 100.00% | 54,028 | Mar 31, 2024 |
| HRT FINANCIAL LP | 0.01% | 0.00% | 16,965 | 16,965 | 100.00% | 40,000 | Mar 31, 2024 |
| KESTRA ADVISORY SERVICES, LLC | 0.01% | 0.00% | 14,500 | 14,500 | 100.00% | 34,800 | Mar 31, 2024 |
| NORTH STAR ASSET MANAGEMENT INC | 0.01% | 0.00% | 12,550 | 12,550 | 100.00% | 30,120 | Mar 31, 2024 |
| COYLE FINANCIAL COUNSEL LLC | 0.01% | 0.01% | 12,500 | 12,500 | 100.00% | 30,000 | Mar 31, 2024 |
| VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.02% | 12,415 | 12,415 | 100.00% | 29,796 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.00% | - | 10,843 | 10,843 | 100.00% | 26,023 | Mar 31, 2024 |
| CETERA ADVISORS LLC | 0.00% | 0.00% | 10,675 | 10,675 | 100.00% | 25,620 | Mar 31, 2024 |
| RIVER WEALTH ADVISORS LLC | 0.00% | 0.00% | 10,000 | 10,000 | 100.00% | 24,000 | Mar 31, 2024 |
| NORDWAND ADVISORS, LLC | 0.00% | 0.00% | 4,000 | 4,000 | 100.00% | 9,600 | Mar 31, 2024 |
| US BANCORP \DE\ | 0.00% | - | 1,200 | 1,200 | 100.00% | 2,880 | Mar 31, 2024 |
| COMERICA BANK | 0.00% | - | 122 | 122 | 100.00% | 293,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 21 | 21 | 100.00% | 50 | Mar 31, 2024 |
Lexicon Pharmaceuticals's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 3.54M shares, valued at $8.50M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -412,175 | -100.00% | - | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -359,210 | -100.00% | - | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -323,968 | -100.00% | - | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -282,467 | -100.00% | - | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -103,144 | -100.00% | - | Mar 31, 2024 |
| AMUNDI | - | - | - | -54,532 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -54,248 | -100.00% | - | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -47,101 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -38,268 | -100.00% | - | Mar 31, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -33,400 | -100.00% | - | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -32,119 | -100.00% | - | Mar 31, 2024 |
| RPO LLC | - | - | - | -32,000 | -100.00% | - | Mar 31, 2024 |
| OPPENHEIMER & CO INC | - | - | - | -24,500 | -100.00% | - | Mar 31, 2024 |
| CANTOR FITZGERALD, L. P. | - | - | - | -16,522 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -16,054 | -100.00% | - | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -14,400 | -100.00% | - | Mar 31, 2024 |
| ASSETMARK, INC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -242 | -100.00% | - | Mar 31, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -204 | -100.00% | - | Mar 31, 2024 |
| JNBA FINANCIAL ADVISORS | - | - | - | -13 | -100.00% | - | Mar 31, 2024 |
Lexicon Pharmaceuticals's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.41M shares, valued at -, as of undefined.
Lexicon Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Federated Hermes MDT Series | 0.69% | 1,694,584 | - | - | Jan 31, 2024 |
| Monteagle Funds | 0.38% | 15,600 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.17% | 250,923 | 129,212 | 106.16% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.17% | 84,532 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.07% | 1,584 | - | - | Dec 31, 2023 |
| FORUM FUNDS II | 0.05% | 50,162 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 135,500 | - | - | Dec 29, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.05% | 1,422,974 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 542,066 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 14,403 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 159,542 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 75,766 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,087,400 | - | - | Feb 29, 2024 |
| SSGA FUNDS | 0.02% | 7,167 | - | - | Feb 29, 2024 |
| AMG FUNDS III | 0.02% | 2,624 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 6,908,982 | 1,785,825 | 34.86% | Dec 31, 2023 |
| Lattice Strategies Trust | 0.01% | 25,162 | - | - | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 79,058 | - | - | Aug 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 11,697 | - | - | Dec 29, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,763 | - | - | Dec 31, 2023 |
| GPS Funds I | 0.01% | 34,436 | - | - | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.01% | 36,367 | - | - | Mar 31, 2020 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,228,735 | 74,578 | 6.46% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 623,861 | 22,182 | 3.69% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 81,719 | - | - | Dec 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 31,571 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 45,209 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,367 | - | - | Dec 31, 2023 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 33,448 | - | - | Dec 31, 2023 |
| VANGUARD HORIZON FUNDS | 0.00% | 43,089 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 528,068 | 39,254 | 8.03% | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 16,015 | - | - | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 1,465,284 | - | - | Feb 29, 2024 |
| TIMOTHY PLAN | 0.00% | 5,824 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 37,359 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 491,608 | 170,068 | 52.89% | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 4,215 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 202,626 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 340 | - | - | Apr 30, 2021 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 5,400 | -22,500 | -80.65% | Dec 31, 2023 |
| PFM Multi-Manager Series Trust | 0.00% | 500 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,227 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT CO | 0.00% | 132,690 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 12,224 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 413,790 | 18,190 | 4.60% | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 31,021 | 8,300 | 36.53% | Dec 31, 2023 |
| Legg Mason ETF Investment Trust | 0.00% | 11,082 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 4,516 | - | - | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 70,439 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 3,623,099 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 228,057 | - | - | Jan 31, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 180,000 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 409,942 | 49,373 | 13.69% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 845 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 224,890 | - | - | Dec 31, 2023 |
| Victory Portfolios II | 0.00% | 10,585 | - | - | Dec 31, 2023 |
| PGIM ETF TRUST | 0.00% | 11,691 | - | - | Feb 29, 2024 |
| WisdomTree Trust | 0.00% | 353,947 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 1,320 | 541 | 69.45% | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 13,143 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 31,873 | 4,281 | 15.52% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,160 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 37,766 | 13,936 | 58.48% | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 419 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 12,745 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 2,560 | - | - | Dec 29, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 8,796 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,768 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,276 | -213 | -2.03% | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 5,000 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 311,756 | 1,876 | 0.61% | Dec 29, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 29,980 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 12,789 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 408 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 7,385 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 51,996 | -125,773 | -70.75% | Dec 29, 2023 |
| VICTORY PORTFOLIOS | 0.00% | 1,505 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 55 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 3,572 | - | - | Jan 31, 2024 |
| Janus Detroit Street Trust | 0.00% | 6,034 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 2,353 | 2,353 | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 16,936 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust I | 0.00% | 391,610 | 5,540 | 1.43% | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 76,516 | -4,300 | -5.32% | Dec 31, 2023 |
| PACE SELECT ADVISORS TRUST | 0.00% | 10,899 | - | - | Jan 31, 2024 |
| AMERICAN BEACON FUNDS | 0.00% | 118,334 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 10,496 | -42 | -0.40% | Jan 31, 2024 |
| Meeder Funds | 0.00% | 122 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,519 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 67,765 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 18,697 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 202 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 28,658 | - | - | Dec 31, 2023 |
| iShares U.S. ETF Trust | 0.00% | 1,166 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 33,964 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 17,930 | -24,267 | -57.51% | Dec 31, 2023 |
| VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00% | 13,949 | - | - | Jan 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,808 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 5,834 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 26,636 | - | - | Dec 31, 2023 |
Lexicon Pharmaceuticals's largest mutual fund holder by % of total assets is "Federated Hermes MDT Series", owning 1.69M shares, compromising 0.69% of its total assets.
Lexicon Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 65 | -39.25% |
| 31 Dec, 23 | 107 | -3.60% |
| 30 Sep, 23 | 111 | -10.48% |
| 30 Jun, 23 | 124 | 20.39% |
| 31 Mar, 23 | 103 | - |
| 31 Dec, 22 | 103 | 7.29% |
| 30 Sep, 22 | 96 | 10.34% |
| 30 Jun, 22 | 87 | -13.86% |
| 31 Mar, 22 | 101 | -11.40% |
| 31 Dec, 21 | 114 | 15.15% |
| 30 Sep, 21 | 99 | -11.61% |
| 30 Jun, 21 | 112 | 2.75% |
| 31 Mar, 21 | 109 | 0.93% |
| 31 Dec, 20 | 108 | 17.39% |
| 30 Sep, 20 | 92 | -14.02% |
| 30 Jun, 20 | 107 | -4.46% |
| 31 Mar, 20 | 112 | -6.67% |
| 31 Dec, 19 | 120 | 12.15% |
| 30 Sep, 19 | 107 | -6.96% |
| 30 Jun, 19 | 115 | -9.45% |
| 31 Mar, 19 | 127 | 0.79% |
| 31 Dec, 18 | 126 | - |
| 30 Sep, 18 | 126 | -1.56% |
| 30 Jun, 18 | 128 | 0.79% |
| 31 Mar, 18 | 127 | -3.05% |
| 31 Dec, 17 | 131 | -10.27% |
| 30 Sep, 17 | 146 | 3.55% |
| 30 Jun, 17 | 141 | -1.40% |
| 31 Mar, 17 | 143 | -4.03% |
| 31 Dec, 16 | 149 | 1.36% |
| 30 Sep, 16 | 147 | 3.52% |
| 30 Jun, 16 | 142 | 8.40% |
| 31 Mar, 16 | 131 | 6.50% |
| 31 Dec, 15 | 123 | 17.14% |
| 30 Sep, 15 | 105 | 23.53% |
| 30 Jun, 15 | 85 | - |
As of 31 Mar 24, 65 institutions are holding Lexicon Pharmaceuticals's shares, representing a decrease of -39.25% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 153,343,347 | -15.93% |
| 31 Dec, 23 | 182,407,025 | -3.19% |
| 30 Sep, 23 | 188,425,746 | -1.34% |
| 30 Jun, 23 | 190,987,897 | 31.23% |
| 31 Mar, 23 | 145,533,477 | -0.87% |
| 31 Dec, 22 | 146,811,759 | -1.32% |
| 30 Sep, 22 | 148,769,066 | 25.35% |
| 30 Jun, 22 | 118,686,853 | -1.11% |
| 31 Mar, 22 | 120,021,967 | -1.14% |
| 31 Dec, 21 | 121,411,231 | 0.37% |
| 30 Sep, 21 | 120,966,324 | 2.83% |
| 30 Jun, 21 | 117,639,848 | -2.94% |
| 31 Mar, 21 | 121,202,374 | -0.59% |
| 31 Dec, 20 | 121,927,573 | 16.95% |
| 30 Sep, 20 | 104,253,690 | -2.70% |
| 30 Jun, 20 | 107,141,949 | 2.24% |
| 31 Mar, 20 | 104,799,519 | -2.15% |
| 31 Dec, 19 | 107,104,778 | 4.60% |
| 30 Sep, 19 | 102,390,646 | -3.11% |
| 30 Jun, 19 | 105,678,795 | 1.15% |
| 31 Mar, 19 | 104,476,802 | -0.74% |
| 31 Dec, 18 | 105,255,610 | -2.06% |
| 30 Sep, 18 | 107,472,461 | -1.20% |
| 30 Jun, 18 | 108,773,871 | -0.87% |
| 31 Mar, 18 | 109,729,174 | -1.42% |
| 31 Dec, 17 | 111,310,428 | -2.99% |
| 30 Sep, 17 | 114,738,062 | 0.26% |
| 30 Jun, 17 | 114,439,280 | 0.21% |
| 31 Mar, 17 | 114,194,683 | 3.50% |
| 31 Dec, 16 | 110,329,061 | -0.02% |
| 30 Sep, 16 | 110,347,242 | -0.34% |
| 30 Jun, 16 | 110,728,727 | -0.02% |
| 31 Mar, 16 | 110,749,292 | 1.34% |
| 31 Dec, 15 | 109,284,091 | 3.32% |
| 30 Sep, 15 | 105,767,678 | 9.27% |
| 30 Jun, 15 | 96,792,385 | - |
Lexicon Pharmaceuticals (LXRX) has 153.34M shares outstanding as of 31 Mar 24, down -15.93% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 69.35% | 1.25% |
| 31 Dec, 23 | 74.47% | 0.88% |
| 30 Sep, 23 | 92.01% | 0.90% |
| 30 Jun, 23 | 101.04% | 1.70% |
| 31 Mar, 23 | 77.00% | 1.27% |
| 31 Dec, 22 | 77.79% | 1.08% |
| 30 Sep, 22 | 85.06% | 1.35% |
| 30 Jun, 22 | 79.33% | 1.23% |
| 31 Mar, 22 | 80.47% | 1.21% |
| 31 Dec, 21 | 81.54% | 1.18% |
| 30 Sep, 21 | 82.96% | 1.25% |
| 30 Jun, 21 | 81.44% | 1.14% |
| 31 Mar, 21 | 84.53% | 0.85% |
| 31 Dec, 20 | 99.65% | 1.06% |
| 30 Sep, 20 | 97.15% | 0.97% |
| 30 Jun, 20 | 100.06% | 1.03% |
| 31 Mar, 20 | 98.37% | 0.97% |
| 31 Dec, 19 | 100.78% | 1.09% |
| 30 Sep, 19 | 96.35% | 0.97% |
| 30 Jun, 19 | 99.44% | 1.02% |
| 31 Mar, 19 | 98.51% | 1.00% |
| 31 Dec, 18 | 99.37% | 0.96% |
| 30 Sep, 18 | 101.50% | 0.96% |
| 30 Jun, 18 | 102.76% | 0.95% |
| 31 Mar, 18 | 103.84% | 0.93% |
| 31 Dec, 17 | 105.77% | 0.90% |
| 30 Sep, 17 | 108.67% | 0.92% |
| 30 Jun, 17 | 108.68% | 0.91% |
| 31 Mar, 17 | 109.32% | 0.97% |
| 31 Dec, 16 | 106.03% | 0.94% |
| 30 Sep, 16 | 106.22% | 0.93% |
| 30 Jun, 16 | 106.64% | 0.93% |
| 31 Mar, 16 | 106.82% | 0.96% |
| 31 Dec, 15 | 105.46% | 1.01% |
| 30 Sep, 15 | 102.08% | 1.17% |
| 30 Jun, 15 | 93.42% | - |
As of 31 Mar 24, Lexicon Pharmaceuticals is held by 69.35% institutional shareholders, representing a 1.25% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 34 | -39.29% |
| 31 Dec, 23 | 56 | 3.70% |
| 30 Sep, 23 | 54 | -32.50% |
| 30 Jun, 23 | 80 | 56.86% |
| 31 Mar, 23 | 51 | - |
| 31 Dec, 22 | 51 | -13.56% |
| 30 Sep, 22 | 59 | 73.53% |
| 30 Jun, 22 | 34 | -20.93% |
| 31 Mar, 22 | 43 | -30.65% |
| 31 Dec, 21 | 62 | 58.97% |
| 30 Sep, 21 | 39 | -37.10% |
| 30 Jun, 21 | 62 | 6.90% |
| 31 Mar, 21 | 58 | 7.41% |
| 31 Dec, 20 | 54 | 45.95% |
| 30 Sep, 20 | 37 | -35.09% |
| 30 Jun, 20 | 57 | 1.79% |
| 31 Mar, 20 | 56 | -3.45% |
| 31 Dec, 19 | 58 | 48.72% |
| 30 Sep, 19 | 39 | -2.50% |
| 30 Jun, 19 | 40 | -28.57% |
| 31 Mar, 19 | 56 | 27.27% |
| 31 Dec, 18 | 44 | - |
| 30 Sep, 18 | 44 | -25.42% |
| 30 Jun, 18 | 59 | 15.69% |
| 31 Mar, 18 | 51 | -10.53% |
| 31 Dec, 17 | 57 | -13.64% |
| 30 Sep, 17 | 66 | 3.13% |
| 30 Jun, 17 | 64 | -9.86% |
| 31 Mar, 17 | 71 | -5.33% |
| 31 Dec, 16 | 75 | -7.41% |
| 30 Sep, 16 | 81 | 3.85% |
| 30 Jun, 16 | 78 | 6.85% |
| 31 Mar, 16 | 73 | 17.74% |
| 31 Dec, 15 | 62 | -6.06% |
| 30 Sep, 15 | 66 | -22.35% |
| 30 Jun, 15 | 85 | - |
34 institutional shareholders have increased their position in LXRX stock as of 31 Mar 24 compared to 56 in the previous quarter (a -39.29% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 12 | -45.45% |
| 31 Dec, 23 | 22 | -24.14% |
| 30 Sep, 23 | 29 | 38.10% |
| 30 Jun, 23 | 21 | -36.36% |
| 31 Mar, 23 | 33 | 13.79% |
| 31 Dec, 22 | 29 | 45.00% |
| 30 Sep, 22 | 20 | -33.33% |
| 30 Jun, 22 | 30 | -16.67% |
| 31 Mar, 22 | 36 | 28.57% |
| 31 Dec, 21 | 28 | -20.00% |
| 30 Sep, 21 | 35 | 25.00% |
| 30 Jun, 21 | 28 | -3.45% |
| 31 Mar, 21 | 29 | -12.12% |
| 31 Dec, 20 | 33 | 26.92% |
| 30 Sep, 20 | 26 | 4.00% |
| 30 Jun, 20 | 25 | -10.71% |
| 31 Mar, 20 | 28 | -15.15% |
| 31 Dec, 19 | 33 | 13.79% |
| 30 Sep, 19 | 29 | -12.12% |
| 30 Jun, 19 | 33 | 6.45% |
| 31 Mar, 19 | 31 | -27.91% |
| 31 Dec, 18 | 43 | - |
| 30 Sep, 18 | 43 | 19.44% |
| 30 Jun, 18 | 36 | 5.88% |
| 31 Mar, 18 | 34 | -10.53% |
| 31 Dec, 17 | 38 | 18.75% |
| 30 Sep, 17 | 32 | -28.89% |
| 30 Jun, 17 | 45 | 7.14% |
| 31 Mar, 17 | 42 | 10.53% |
| 31 Dec, 16 | 38 | -9.52% |
| 30 Sep, 16 | 42 | 13.51% |
| 30 Jun, 16 | 37 | 19.35% |
| 31 Mar, 16 | 31 | -13.89% |
| 31 Dec, 15 | 36 | 71.43% |
| 30 Sep, 15 | 21 | - |
| 30 Jun, 15 | - | - |
12 institutional shareholders have reduced their position in LXRX stock as of 31 Mar 24 compared to 22 in the previous quarter (a -45.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 65 | -39.25% | 153,343,347 | -15.93% | 69.35% | 1.25% | 34 | -39.29% | 12 | -45.45% |
| 31 Dec, 23 | 107 | -3.60% | 182,407,025 | -3.19% | 74.47% | 0.88% | 56 | 3.70% | 22 | -24.14% |
| 30 Sep, 23 | 111 | -10.48% | 188,425,746 | -1.34% | 92.01% | 0.90% | 54 | -32.50% | 29 | 38.10% |
| 30 Jun, 23 | 124 | 20.39% | 190,987,897 | 31.23% | 101.04% | 1.70% | 80 | 56.86% | 21 | -36.36% |
| 31 Mar, 23 | 103 | - | 145,533,477 | -0.87% | 77.00% | 1.27% | 51 | - | 33 | 13.79% |
| 31 Dec, 22 | 103 | 7.29% | 146,811,759 | -1.32% | 77.79% | 1.08% | 51 | -13.56% | 29 | 45.00% |
| 30 Sep, 22 | 96 | 10.34% | 148,769,066 | 25.35% | 85.06% | 1.35% | 59 | 73.53% | 20 | -33.33% |
| 30 Jun, 22 | 87 | -13.86% | 118,686,853 | -1.11% | 79.33% | 1.23% | 34 | -20.93% | 30 | -16.67% |
| 31 Mar, 22 | 101 | -11.40% | 120,021,967 | -1.14% | 80.47% | 1.21% | 43 | -30.65% | 36 | 28.57% |
| 31 Dec, 21 | 114 | 15.15% | 121,411,231 | 0.37% | 81.54% | 1.18% | 62 | 58.97% | 28 | -20.00% |
| 30 Sep, 21 | 99 | -11.61% | 120,966,324 | 2.83% | 82.96% | 1.25% | 39 | -37.10% | 35 | 25.00% |
| 30 Jun, 21 | 112 | 2.75% | 117,639,848 | -2.94% | 81.44% | 1.14% | 62 | 6.90% | 28 | -3.45% |
| 31 Mar, 21 | 109 | 0.93% | 121,202,374 | -0.59% | 84.53% | 0.85% | 58 | 7.41% | 29 | -12.12% |
| 31 Dec, 20 | 108 | 17.39% | 121,927,573 | 16.95% | 99.65% | 1.06% | 54 | 45.95% | 33 | 26.92% |
| 30 Sep, 20 | 92 | -14.02% | 104,253,690 | -2.70% | 97.15% | 0.97% | 37 | -35.09% | 26 | 4.00% |
| 30 Jun, 20 | 107 | -4.46% | 107,141,949 | 2.24% | 100.06% | 1.03% | 57 | 1.79% | 25 | -10.71% |
| 31 Mar, 20 | 112 | -6.67% | 104,799,519 | -2.15% | 98.37% | 0.97% | 56 | -3.45% | 28 | -15.15% |
| 31 Dec, 19 | 120 | 12.15% | 107,104,778 | 4.60% | 100.78% | 1.09% | 58 | 48.72% | 33 | 13.79% |
| 30 Sep, 19 | 107 | -6.96% | 102,390,646 | -3.11% | 96.35% | 0.97% | 39 | -2.50% | 29 | -12.12% |
| 30 Jun, 19 | 115 | -9.45% | 105,678,795 | 1.15% | 99.44% | 1.02% | 40 | -28.57% | 33 | 6.45% |
| 31 Mar, 19 | 127 | 0.79% | 104,476,802 | -0.74% | 98.51% | 1.00% | 56 | 27.27% | 31 | -27.91% |
| 31 Dec, 18 | 126 | - | 105,255,610 | -2.06% | 99.37% | 0.96% | 44 | - | 43 | - |
| 30 Sep, 18 | 126 | -1.56% | 107,472,461 | -1.20% | 101.50% | 0.96% | 44 | -25.42% | 43 | 19.44% |
| 30 Jun, 18 | 128 | 0.79% | 108,773,871 | -0.87% | 102.76% | 0.95% | 59 | 15.69% | 36 | 5.88% |
| 31 Mar, 18 | 127 | -3.05% | 109,729,174 | -1.42% | 103.84% | 0.93% | 51 | -10.53% | 34 | -10.53% |
| 31 Dec, 17 | 131 | -10.27% | 111,310,428 | -2.99% | 105.77% | 0.90% | 57 | -13.64% | 38 | 18.75% |
| 30 Sep, 17 | 146 | 3.55% | 114,738,062 | 0.26% | 108.67% | 0.92% | 66 | 3.13% | 32 | -28.89% |
| 30 Jun, 17 | 141 | -1.40% | 114,439,280 | 0.21% | 108.68% | 0.91% | 64 | -9.86% | 45 | 7.14% |
| 31 Mar, 17 | 143 | -4.03% | 114,194,683 | 3.50% | 109.32% | 0.97% | 71 | -5.33% | 42 | 10.53% |
| 31 Dec, 16 | 149 | 1.36% | 110,329,061 | -0.02% | 106.03% | 0.94% | 75 | -7.41% | 38 | -9.52% |
| 30 Sep, 16 | 147 | 3.52% | 110,347,242 | -0.34% | 106.22% | 0.93% | 81 | 3.85% | 42 | 13.51% |
| 30 Jun, 16 | 142 | 8.40% | 110,728,727 | -0.02% | 106.64% | 0.93% | 78 | 6.85% | 37 | 19.35% |
| 31 Mar, 16 | 131 | 6.50% | 110,749,292 | 1.34% | 106.82% | 0.96% | 73 | 17.74% | 31 | -13.89% |
| 31 Dec, 15 | 123 | 17.14% | 109,284,091 | 3.32% | 105.46% | 1.01% | 62 | -6.06% | 36 | 71.43% |
| 30 Sep, 15 | 105 | 23.53% | 105,767,678 | 9.27% | 102.08% | 1.17% | 66 | -22.35% | 21 | - |
| 30 Jun, 15 | 85 | - | 96,792,385 | - | 93.42% | - | 85 | - | - | - |
Lexicon Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Lexicon Pharmaceuticals's stock was made by Artal International S.C.A. on May 14 2024, selling 1,150,922 shares at - per share (valued at -).
Lexicon Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 22 | 7 | 314.29% |
| Q1 2024 | 41 | 30 | 136.67% |
| Q4 2023 | 6 | - | - |
| Q3 2023 | 3 | - | - |
| Q2 2023 | 32 | 8 | 400.00% |
| Q1 2023 | 41 | 32 | 128.13% |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 18 | 7 | 257.14% |
| Q1 2022 | 40 | 27 | 148.15% |
| Q4 2021 | - | 19 | - |
| Q3 2021 | 1 | 7 | 14.29% |
| Q2 2021 | 24 | 8 | 300.00% |
| Q1 2021 | 37 | 27 | 137.04% |
| Q4 2020 | 2 | 2 | 100.00% |
| Q2 2020 | 31 | 15 | 206.67% |
| Q1 2020 | 47 | 38 | 123.68% |
| Q4 2019 | - | 13 | - |
| Q3 2019 | 124 | - | - |
| Q2 2019 | 16 | - | - |
| Q1 2019 | 39 | 31 | 125.81% |
22 total buy trades, and 7 total sell trades (buy/sell ratio of 3.14%) were made by Lexicon Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 5 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | 2 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 124 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lexicon Pharmaceuticals's stocks.
Lexicon Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| TERN | Terns Pharmaceuticals, Inc. |
| CWBR | CohBar, Inc. |
| GRTX | Galera Therapeutics, Inc. |
| MREO | Mereo BioPharma Group plc |
| XFOR | X4 Pharmaceuticals, Inc. |
| ELEV | Elevation Oncology, Inc. |
| BLRX | BioLineRx Ltd. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| ARDX | Ardelyx, Inc. |
| OCEA | Ocean Biomedical, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| IBRX | ImmunityBio, Inc. |
| ENVB | Enveric Biosciences, Inc. |
| AVRO | AVROBIO, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
LXRX Ownership FAQ
Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals is owned by institutional shareholders (69.35%), insiders (1.15%), and public (29.51%). The largest institutional shareholder of Lexicon Pharmaceuticals is ARTAL GROUP S.A. (53.16% of total shares) and the top mutual fund owner is Federated Hermes MDT Series (0.69% of total shares).
Who are the major institutional shareholders of Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals's major institutional shareholders are ARTAL GROUP S.A., FMR LLC, BLACKROCK INC., VANGUARD GROUP INC, and ORBIMED ADVISORS LLC. The top five shareholders own together 67.42% of the company's share outstanding.
How many Lexicon Pharmaceuticals shareholders are there?
As of Mar 2024, there are 65 institutional shareholders of Lexicon Pharmaceuticals.
What percentage of Lexicon Pharmaceuticals is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A owns 117.55M shares of Lexicon Pharmaceuticals, representing 53.16% of the company's total shares outstanding, valued at $282.13M (as of Mar 2024).
What percentage of Lexicon Pharmaceuticals is owned by FMR LLC?
As of Mar 2024, FMR LLC holds 13.89M shares of Lexicon Pharmaceuticals (LXRX), compromising 6.28% of the company, valued at $33.35M.
What percentage of Lexicon Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Lexicon Pharmaceuticals. The company owns 7.69M of the company's shares outstanding (worth $18.46M).